First-pass extracted concept

HIV-1 Tat and methamphetamine synergistic basal ganglia neurotoxicity

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

This review topic synthesizes evidence that methamphetamine and HIV-1 Tat jointly damage basal ganglia and dopaminergic systems. It is useful as a mechanistic framing concept rather than as a deployable tool.

Source 1DOI PubMed

What problem it solves

It helps explain why HIV-1 infection with concurrent methamphetamine abuse is associated with worsened neurodegeneration and faster progression of HIV-associated dementia.

Source 1DOI PubMed

What it does not solve

The abstract does not provide a specific intervention, assay protocol, or engineered construct that would directly mitigate or measure this injury.

Source 1DOI PubMed

Evidence Snippets

The aim of this review is to update the reader on the current knowledge of MA and HIV-1 neurotoxicity, specifically Tat, and discuss the progress in understanding how MA synergizes with the HIV-1 transactivator protein Tat to damage the basal ganglia.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1review2007Current HIV ResearchDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1disease interaction summarysupports2007Source 1DOI PubMed

Concurrent HIV-1 infection and methamphetamine abuse are associated with exacerbated neurodegenerative changes and more rapid progression of HIV-1-associated dementia.

Quoted textsource-backed

HIV-1 infection with concurrent methamphetamine (MA) abuse results in exacerbated neurodegenerative changes and rapid progression of a form of sub-cortical dementia termed HIV-1 associated dementia (HAD).

Claim 2pathophysiology summarysupports2007Source 1DOI PubMed

A notable feature of HIV-1-associated dementia is involvement of the dopaminergic system with parkinsonian-like movement abnormalities.

Quoted textsource-backed

A notable feature of HAD is the involvement of the dopaminergic system manifested as parkinsonian like movement abnormalities.

Claim 3synergy summarysupports2007Source 1DOI PubMed

The review frames methamphetamine and HIV-1 Tat as synergizing to damage the basal ganglia and injure the dopaminergic system.

Quoted textsource-backed

Understanding the interaction of Tat and MA in the basal ganglia and the resultant injury to the dopaminergic system in rodent models as well as cell culture will shed light on the dopaminergic pathology occurring in HIV-1 infected-MA abusers. The aim of this review is to update the reader on the current knowledge of MA and HIV-1 neurotoxicity, specifically Tat, and discuss the progress in understanding how MA synergizes with the HIV-1 transactivator protein Tat to damage the basal ganglia.